Detalhe da pesquisa
1.
Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors.
Cancer Immunol Immunother
; 70(3): 763-772, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989552